DEFENCATH (TAUROLIDINE AND HEPARIN)
DEFENCATH (TAUROLIDINE AND HEPARIN) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: DEFENCATH; Generic name: TAUROLIDINE AND HEPARIN; Drug class: Anti-coagulant [EPC].
| Brand name | DEFENCATH |
|---|---|
| Generic name | TAUROLIDINE AND HEPARIN |
| Drug class | Anti-coagulant [EPC] |
| Manufacturer | CorMedix Inc. |
| Used for | 1 INDICATIONS AND USAGE LIMITED POPULATION: DEFENCATH ® is indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis (HD) through a central venous catheter (CVC). This drug is indicated for use in a limited and specific population of patients [see Clinical Studies (14) ]. Limitations of Use The safety and effectiveness of DEFENCATH have not been established for use in populations other than adult patients with kidney failure receiving chronic HD through a CVC. LIMITED POPULATION: DEFENCATH is a combination of taurolidine, a thiadiazinane antimicrobial, and heparin, an anti-coagulant, indicated to |
| Dosage | 2 DOSAGE AND ADMINISTRATION DEFENCATH is for instillation into CVCs only [see Indications and Usage (1) ]. DEFENCATH is not intended for systemic administration. Do not use DEFENCATH as a catheter lock flush product. Withdraw a sufficient volume of DEFENCATH catheter lock solution (CLS) from the vial using a sterile needle and syringe to fill the catheter lumens. Use 3 mL or 5 mL single-dose vial (depending on the volume of the catheter lumens) to instill DEFENCATH into each catheter lumen at th |
| Active ingredient(s) | HEPARIN |
| Route | INTRALUMINAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=13b3a61e-5a4b-4afb-8fa1-d76ebdb344d6 |